A tool for monitoring cell type-specific focused ultrasound neuromodulation and control of chronic epilepsy

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 119; no. 46; p. e2206828119
• Main Authors: Murphy, Keith R, Farrell, Jordan S, Gomez, Juan L, Stedman, Quintin G, Li, Ningrui, Leung, Steven A, Good, Cameron H, Qiu, Zhihai, Firouzi, Kamyar, Butts Pauly, Kim, Khuri-Yakub, Butrus Pierre T, Michaelides, Michael, Soltesz, Ivan, de Lecea, Luis
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 15-11-2022
• Subjects: Animals; Biological Sciences; Brain; Brain - diagnostic imaging; Brain - physiology; Epilepsy; Epilepsy - therapy; Epilepsy, Temporal Lobe; Hippocampus; Hippocampus - diagnostic imaging; Interneurons; Monitoring; Neuroimaging; Neuromodulation; Parameter identification; Parvalbumin; Photometry; Temporal lobe; Ultrasonic imaging; Ultrasonography; Ultrasound; epilepsy; neuromodulation; photometry; neuroscience; focused ultrasound
• ISSN: 0027-8424; 1091-6490; 1091-6490
• DOI: 10.1073/pnas.2206828119

Focused ultrasound (FUS) is a powerful tool for noninvasive modulation of deep brain activity with promising therapeutic potential for refractory epilepsy; however, tools for examining FUS effects on specific cell types within the deep brain do not yet exist. Consequently, how cell types within heterogeneous networks can be modulated and whether parameters can be identified to bias these networks in the context of complex behaviors remains unknown. To address this, we developed a fiber Photometry Coupled focused Ultrasound System (PhoCUS) for simultaneously monitoring FUS effects on neural activity of subcortical genetically targeted cell types in freely behaving animals. We identified a parameter set that selectively increases activity of parvalbumin interneurons while suppressing excitatory neurons in the hippocampus. A net inhibitory effect localized to the hippocampus was further confirmed through whole brain metabolic imaging. Finally, these inhibitory selective parameters achieved significant spike suppression in the kainate model of chronic temporal lobe epilepsy, opening the door for future noninvasive therapies.